Preview Mode Links will not work in preview mode

Jul 31, 2023

Featuring a slide presentation and related discussion from Dr Hanny Al-Samkari, including the following topics:

  • Indications for initiation of treatment for patients with immune thrombocytopenia (ITP) and selection of first-line therapy (0:00)
  • Treatment algorithm for ITP in the second line and beyond (7:47)
  • Role of thrombopoietin receptor agonists and fostamatinib for second- and later-line treatment of ITP (14:21)
  • Novel investigational approaches for the treatment of ITP — efgartigimod, rilzabrutinib and ianalumab (28:24)

CME information and select publications